サマリー

医療用品市場は、2022年の1,384億米ドルから2027年には1,635億米ドルに達すると予測され、予測期間中のCAGRは3.4%となる見込みです。この市場の成長を促す主な要因は、世界的な慢性疾患の蔓延、政府による医療事業への投資や取り組みの増加、HAIを抑制するための感染対策需要の高まり、外科手術数の増加、医療機器の需要増加などです。しかし、製品のリコールや医療用品の承認に関する厳しい規制要件が、今後数年間、この市場の成長を抑制する要因になると予想されます。
"2021年の医療用品市場では、挿管・換気用品分野が最大のシェアを占めた"
医療用品市場をタイプ別に分類すると、さらに消毒剤、カテーテル、個人防護具、創傷ケア消耗品、輸液・注射用品、診断用品、放射線学消耗品、挿管・換気用品、睡眠時無呼吸症候群消耗品、滅菌消耗品、透析消耗品、 、その他の医療用品に分類されます。2021年の医療用品市場では、COVID-19の発生による挿管・換気用消耗品の需要増により、挿管・換気用品分野が最大のシェアを占めています。
"その他の用途セグメントは予測期間中に急速な成長を遂げると推定される"
医療用品市場は用途別に、泌尿器科、創傷治療、放射線科、呼吸器、感染管理、循環器、IVD、その他の用途に分類されます。2021年には、その他の用途セグメントが医療用品市場で最大のシェアを占めています。さらに、心臓病学セグメントは予測期間中に最も高いCAGRを記録すると予想されます。このセグメントの高成長は、主に世界的な心血管疾患の有病率の上昇に起因するものである。
"2021年の医療用品市場のエンドユーザーでは、病院セグメントが最大のシェアを占めた"
医療用品市場のエンドユーザーセグメントは、さらに診療所／医院、病院、その他のエンドユーザーに分類されます。2021年に圧倒的なシェアを占めたのは病院セグメントで、これは医療システムへの投資の増加、HAIの蔓延、慢性疾患の高い発生率などが要因である。

"アジア太平洋地域は医療用品の最も成長率の高い地域市場"
2021年の医療用品市場は、さらに北米、欧州、アジア太平洋、ROW（Rest of the World）に分類されます。2021年の市場の圧倒的なシェアは北米地域が占め、同年は欧州が2位のシェアを占めています。しかし、2022年から2027年の予測期間においては、アジア太平洋地域が最も速い成長率で成長すると予想されています。これは、老年人口の拡大、同地域における医療観光産業の進展、慢性疾患の高い負担に起因するものです。これらの要因は、医療用品消耗品の巨大な需要を配置し、この地域の市場成長を推進しています。
主な参加企業の内訳は以下のとおりです。
- 企業タイプ別Tier1：35％、Tier2：45％、Tier3：20％。
- 役職別Cレベル：35％、Directorレベル：25％、その他。40%
- 地域別北米：45％、欧州：20％、アジア太平洋：30％、その他の地域：5

医療機器市場で事業を展開する主な企業は以下の通りです。
- メドトロニック・ピーエルシー(アイルランド)
- カーディナルヘルス（米国）、BD（米国）
- ジョンソン・エンド・ジョンソン社（米国）
- B. ブラウン・メルシュンゲン社（ドイツ）
- ボストン・サイエンティフィック・コーポレーション(米国)
- サーモフィッシャーサイエンティフィック社（米国）
- バクスター(米)
- 3M (米国)
- スミス・アンド・ネフュー (アイルランド)
- コンバテック社（英国）
- アボット（米国）
- クックメディカル（米国）
- メリットメディカルシステムズ（米国）
- ストライカー (米国)
- テルモ (日本)
- テレフレックス・インコーポレイテッド（米国）
- フレゼニウス メディカル ケア AG & Co.KGaA (ドイツ)
- コロプラストグループ（デンマーク）
- ハミルトンメディカル（スイス）
- ACell, Inc.（米国）
- インヴァケア社 (米国)
- メドライン・インダストリーズ社（米国）（Medline Industries, LP.
- デロイヤル・インダストリーズ社（米国）
- Shenzhen MedRena Biotech Co.(中国)
- ケレシス社（米国）
- ホワイトレイ（オーストラリア）

調査範囲
本レポートでは、医療用品市場をタイプ、アプリケーション、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。利害関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供しています。また、ミクロ市場については、その成長動向、展望、医療用品市場全体への貢献度に関して調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、以下のポイントに関する洞察を提供しています。
- 市場の浸透。市場の上位16社が提供する医療用品に関する包括的な情報。レポートでは、医療用品市場を製品別、地域別に分析しています。
- 市場の発展。有利な新興市場に関する包括的な情報。本レポートでは、主要な地域ごとの様々な医療用品市場を分析しています。
- 市場の多様化。医療用品市場における新製品、未開拓の地域、最近の開発、投資に関する徹底的な情報。
- 競争力の評価。医療用品市場における主要企業の市場シェアと戦略に関する詳細な評価

ページTOPに戻る

目次

1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
TABLE 1 INCLUSIONS AND EXCLUSIONS 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
FIGURE 1 MEDICAL SUPPLIES MARKET SEGMENTATION 29
1.3.2 GEOGRAPHIC SCOPE 30
1.3.3 YEARS CONSIDERED 30
1.4 CURRENCY 31
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 31
1.7 LIMITATIONS 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 2 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
TABLE 2 KEY DATA FROM PRIMARY SOURCES 36
2.1.1.2 Key industry insights 37
2.1.2 PRIMARY DATA 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 BLOOD COLLECTION DEVICES MARKET– REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKENSON AND COMPANY 39
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF PRODUCTS FOR THE BLOOD COLLECTION DEVICES MARKET 40
FIGURE 6 CAGR PROJECTIONS 41
FIGURE 7 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 8 DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ANALYSIS 44
2.5 ASSUMPTIONS 44
2.6 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY 45
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS 45
2.7 RISK ASSESSMENT 46
TABLE 3 RISK ASSESSMENT 46
3 EXECUTIVE SUMMARY 47
FIGURE 9 MEDICAL SUPPLIES MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION) 47
FIGURE 10 MEDICAL SUPPLIES MARKET, BY APPLICATION,
2022 VS. 2027 (USD BILLION) 48
FIGURE 11 MEDICAL SUPPLIES MARKET, BY END USER, 2022 VS. 2027 (USD BILLION) 48
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL MEDICAL SUPPLIES MARKET 49
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES FOR MARKET PLAYERS IN THE MEDICAL SUPPLIES MARKET 50
FIGURE 13 THE RISING PREVALENCE OF CHRONIC INFECTIOUS DISEASES DRIVES THE MARKET GROWTH 50
4.2 NORTH AMERICA MEDICAL SUPPLIES MARKET: BY APPLICATION AND COUNTRY (2021) 51
FIGURE 14 THE OTHER APPLICATIONS SEGMENT DOMINATED THE NORTH AMERICA MARKET IN 2021 51
4.3 MEDICAL SUPPLIES MARKET, BY REGION (2022 VS. 2027) 52
FIGURE 15 NORTH AMERICA TO DOMINATE THE MEDICAL SUPPLIES MARKET DURING THE FORECAST PERIOD 52
4.4 MEDICAL SUPPLIES MARKET: GEOGRAPHIC SNAPSHOT 52
FIGURE 16 INDIA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 17 MEDICAL SUPPLIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Growing prevalence of chronic diseases worldwide 54
FIGURE 18 GLOBAL AGE-STANDARDIZED PREVALENCE OF DIABETES,
BY REGION, 2019 VS. 2030 VS. 2045 (%) 54
5.2.1.2 Increasing government-funded investments and initiatives in healthcare projects 55
5.2.1.3 Increasing demand for infection control measures to curb HAIs 55
5.2.1.4 Growing number of surgical procedures worldwide 56
TABLE 4 NUMBER OF SURGICAL PROCEDURES FOR CATARACTS, BY COUNTRY
(2018–2020) 56
5.2.1.5 Increasing demand for medical devices 57
5.2.1.6 Increasing number of ICU beds in hospitals and surgical centers 58
5.2.1.7 Rising number of accidents and trauma cases 58
5.2.2 RESTRAINTS 59
5.2.2.1 Product recalls 59
TABLE 5 MAJOR PRODUCT RECALLS IN 2020 59
5.2.2.2 Stringent regulatory requirements for approval of medical supplies 59
 
5.2.3 OPPORTUNITIES 59
5.2.3.1 Emerging markets 59
5.2.3.2 Rising medical tourism 60
5.2.4 CHALLENGES 60
5.2.4.1 Medication errors and risks associated with medical supplies 60
TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 61
5.2.4.2 Shortage of skilled medical professionals 61
5.2.5 COVID-19 IMPACT ON THE MEDICAL SUPPLIES MARKET 62
5.3 ECOSYSTEM ANALYSIS 63
6 MEDICAL SUPPLIES MARKET, BY TYPE 64
6.1 INTRODUCTION 65
TABLE 7 MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 65
6.2 DIAGNOSTIC SUPPLIES 65
TABLE 8 DIAGNOSTIC SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 66
6.2.1 BLOOD COLLECTION CONSUMABLES 66
6.2.1.1 Rising demand for plasma donation to support demand for blood collection consumables 66
TABLE 9 BLOOD COLLECTION TUBES AVAILABLE IN THE MARKET 67
TABLE 10 BLOOD COLLECTION CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 67
6.2.2 OTHER SAMPLE COLLECTION CONSUMABLES 68
TABLE 11 OTHER SAMPLE COLLECTION CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 68
6.3 DIALYSIS CONSUMABLES 68
FIGURE 19 US: PREVALENCE OF ESRD, BY AGE GROUP, 2010–2018 69
TABLE 12 DIALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 69
6.3.1 PERITONEAL DIALYSIS CONSUMABLES 70
6.3.1.1 Benefits such as ease-of-use to support growth of this segment 70
TABLE 13 PERITONEAL DIALYSIS CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 70
6.3.2 HEMODIALYSIS CONSUMABLES 70
6.3.2.1 Rising demand for home dialysis to support growth of the hemodialysis consumables segment 70
TABLE 14 HEMODIALYSIS CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 71
6.4 WOUND CARE CONSUMABLES 71
TABLE 15 WOUND CARE CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 71
6.4.1 ADVANCED WOUND DRESSINGS 72
6.4.1.1 Launch of advanced wound dressings to drive market growth 72
TABLE 16 ADVANCED WOUND DRESSINGS MARKET, BY REGION,
2019–2027 (USD MILLION) 72
6.4.2 SURGICAL WOUND CARE CONSUMABLES 73
6.4.2.1 Product launches by major players to accelerate demand 73
TABLE 17 SURGICAL WOUND CARE CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 73
6.4.3 TRADITIONAL WOUND CARE CONSUMABLES 74
6.4.3.1 Growing adoption of advanced wound care products to limit market 74
TABLE 18 TRADITIONAL WOUND CARE CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 74
6.5 RADIOLOGY CONSUMABLES 74
6.5.1 ESTABLISHMENT OF ADVANCED IMAGING CENTERS TO DRIVE DEMAND 74
TABLE 19 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS,
BY COUNTRY, 2010 VS. 2018 75
TABLE 20 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2010 VS. 2018 76
TABLE 21 RADIOLOGY CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 76
6.6 DISINFECTANTS 76
TABLE 22 DISINFECTANTS MARKET, BY TYPE, 2019–2027 (USD MILLION) 77
6.6.1 HAND DISINFECTANTS 77
6.6.1.1 Increasing health awareness to drive growth 77
TABLE 23 HAND DISINFECTANTS MARKET, BY REGION, 2019–2027 (USD MILLION) 78
6.6.2 SKIN DISINFECTANTS 78
6.6.2.1 Rising awareness for SSIs and HAIs to boost market 78
TABLE 24 SKIN DISINFECTANTS MARKET, BY REGION, 2019–2027 (USD MILLION) 78
6.6.3 SURFACE DISINFECTANTS 79
6.6.3.1 Surface disinfectants limits transfer of microorganisms transmitted through hand-to-surface contact 79
TABLE 25 SURFACE DISINFECTANTS OFFERED BY SOME MARKET PLAYERS 79
TABLE 26 SURFACE DISINFECTANTS MARKET, BY REGION, 2019–2027 (USD MILLION) 80
6.6.4 INSTRUMENT DISINFECTANTS 80
6.6.4.1 Growing number of surgical procedures to ensure cleanliness to drive growth 80
TABLE 27 INSTRUMENT DISINFECTANTS OFFERED BY SOME MARKET PLAYERS 81
TABLE 28 INSTRUMENT DISINFECTANTS MARKET, BY REGION,
2019–2027 (USD MILLION) 81
6.7 INFUSION & INJECTABLE SUPPLIES 81
6.7.1 INCREASING USE OF INFUSION & INJECTABLE SUPPLIES FOR DRUG DELIVERY TO DRIVE MARKET 81
TABLE 29 INFUSION & INJECTABLE SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 82
6.8 INTUBATION & VENTILATION SUPPLIES 82
6.8.1 HIGH DEMAND FOR INTUBATION & VENTILATION SUPPLIES DUE TO COVID-19 82
TABLE 30 INTUBATION & VENTILATION SUPPLIES MARKET, BY REGION,
2019–2027 (USD MILLION) 83
6.9 PERSONAL PROTECTIVE EQUIPMENT 83
TABLE 31 PPE MARKET, BY TYPE, 2019–2027 (USD MILLION) 83
6.9.1 HAND & ARM PROTECTION EQUIPMENT 84
6.9.1.1 FDA guidelines for the use of gloves to prevent COVID-19 to drive market growth 84
TABLE 32 HAND & ARM PROTECTION EQUIPMENT MARKET, BY REGION,
2019–2027 (USD MILLION) 84
6.9.2 EYE & FACE PROTECTION EQUIPMENT 84
6.9.2.1 Measures undertaken to curtail the spread of COVID-19 to drive growth 84
TABLE 33 EYE & FACE PROTECTION EQUIPMENT MARKET, BY REGION,
2019–2027 (USD MILLION) 85
6.9.3 PROTECTIVE CLOTHING 85
6.9.3.1 Growing risk of cross-contamination during surgery to drive the growth 85
TABLE 34 PROTECTIVE CLOTHING MARKET, BY REGION, 2019–2027 (USD MILLION) 85
6.9.4 FOOT & LEG PROTECTION EQUIPMENT 86
6.9.4.1 Rising need to reduce contamination in healthcare settings to promote growth 86
TABLE 35 FOOT & LEG PROTECTION EQUIPMENT MARKET, BY REGION,
2019–2027 (USD MILLION) 86
6.9.5 SURGICAL DRAPES 86
6.9.5.1 Rising need to reduce contamination in healthcare settings to promote growth 86
TABLE 36 SURGICAL DRAPES MARKET, BY REGION, 2019–2027 (USD MILLION) 87
6.9.6 OTHER PROTECTIVE EQUIPMENT 87
TABLE 37 OTHER PROTECTIVE EQUIPMENT MARKET, BY REGION,
2019–2027 (USD MILLION) 87
6.10 STERILIZATION CONSUMABLES 88
6.10.1 INCREASING NUMBER OF HOSPITAL STERILIZATION PROCEDURES TO DRIVE DEMAND 88
TABLE 38 BIOLOGICAL INDICATORS OFFERED BY KEY MARKET PLAYERS 88
TABLE 39 STERILIZATION POUCHES OFFERED BY SOME MARKET PLAYERS 89
TABLE 40 STERILIZATION CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 89
6.11 CATHETERS 89
TABLE 41 CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 90
6.11.1 CARDIOVASCULAR CATHETERS 90
6.11.1.1 High prevalence of atrial fibrillation to drive the demand 90
TABLE 42 CARDIOVASCULAR CATHETERS MARKET, BY REGION,
2019–2027 (USD MILLION) 90
6.11.2 INTRAVENOUS CATHETERS 91
6.11.2.1 Growing prevalence of chronic diseases to support market growth 91
TABLE 43 INTRAVENOUS CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 91
6.11.3 UROLOGICAL CATHETERS 91
6.11.3.1 Launch of innovative products to drive demand 91
TABLE 44 UROLOGICAL CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 92
 
6.11.4 SPECIALTY CATHETERS 92
6.11.4.1 Growing use in intrauterine and other specialty catheterizations to support growth 92
TABLE 45 SPECIALTY CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 93
6.11.5 NEUROVASCULAR CATHETERS 93
6.11.5.1 Increasing incidence of neurovascular diseases to support market 93
TABLE 46 NEUROVASCULAR CATHETERS MARKET, BY REGION,
2019–2027 (USD MILLION) 93
6.12 SLEEP APNEA CONSUMABLES 94
6.12.1 GROWING PREVALENCE OF SLEEP APNEA TO SUPPORT MARKET 94
TABLE 47 SLEEP APNEA CONSUMABLES MARKET, BY REGION,
2019–2027 (USD MILLION) 94
6.13 OTHER MEDICAL SUPPLIES 95
TABLE 48 OTHER MEDICAL SUPPLIES MARKET, BY REGION,
2019–2027 (USD MILLION) 95
7 MEDICAL SUPPLIES MARKET, BY APPLICATION 96
7.1 INTRODUCTION 97
TABLE 49 MEDICAL SUPPLIES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 97
7.2 UROLOGY 98
7.2.1 INCREASING PREVALENCE OF KIDNEY DISORDERS TO SUPPORT MARKET 98
TABLE 50 BLADDER CANCER INCIDENCE, BY REGION, 2018 VS. 2025 98
TABLE 51 KIDNEY CANCER INCIDENCE, BY REGION, 2018 VS. 2025 98
TABLE 52 PROSTATE CANCER INCIDENCE, BY REGION, 2018 VS. 2025 99
TABLE 53 MEDICAL SUPPLIES MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2019–2027 (USD MILLION) 99
7.3 WOUND CARE 99
7.3.1 INNOVATIVE LAUNCHES OF WOUND CARE PRODUCTS TO DRIVE DEMAND 99
TABLE 54 MEDICAL SUPPLIES MARKET FOR WOUND CARE APPLICATIONS, BY REGION, 2019–2027 (USD MILLION) 100
7.4 RADIOLOGY 100
7.4.1 RISING NUMBER OF RADIOLOGICAL PROCEDURES TO SUPPORT MARKET 100
TABLE 55 INDICATIVE LIST OF RESEARCH STUDIES 101
TABLE 56 MEDICAL SUPPLIES MARKET FOR RADIOLOGY APPLICATIONS, BY REGION, 2019–2027 (USD MILLION) 102
7.5 RESPIRATORY 102
7.5.1 RISING INCIDENCE OF CHRONIC RESPIRATORY DISEASES PROPELS DEMAND 102
TABLE 57 MEDICAL SUPPLIES MARKET FOR RESPIRATORY APPLICATIONS, BY REGION, 2019–2027 (USD MILLION) 103
7.6 INFECTION CONTROL 103
7.6.1 INCREASING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO SUPPORT MARKET 103
TABLE 58 MEDICAL SUPPLIES MARKET FOR INFECTION CONTROL APPLICATIONS,
BY REGION, 2019–2027 (USD MILLION) 104
7.7 CARDIOLOGY 104
7.7.1 INCREASING PREVALENCE OF CVD WORLDWIDE TO SUPPORT GROWTH 104
TABLE 59 MEDICAL SUPPLIES MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2019–2027 (USD MILLION) 105
7.8 IN VITRO DIAGNOSTICS 105
7.8.1 INCREASING ADOPTION OF POINT-OF-CARE TESTS TO SUPPORT MARKET 105
TABLE 60 MEDICAL SUPPLIES MARKET FOR IVD APPLICATIONS, BY REGION,
2019–2027 (USD MILLION) 105
7.9 OTHER APPLICATIONS 106
TABLE 61 MEDICAL SUPPLIES MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2027 (USD MILLION) 107
8 MEDICAL SUPPLIES MARKET, BY END USER 108
8.1 INTRODUCTION 109
TABLE 62 MEDICAL SUPPLIES MARKET, BY END USER, 2019–2027 (USD MILLION) 109
8.2 HOSPITALS 109
8.2.1 INCREASING INVESTMENTS IN HEALTHCARE SYSTEMS TO SUPPORT GROWTH 109
TABLE 63 MEDICAL SUPPLIES MARKET FOR HOSPITALS, BY REGION,
2019–2027 (USD MILLION) 110
8.3 CLINICS/PHYSICIAN OFFICES 111
8.3.1 DIAGNOSTIC AND PREVENTIVE CARE FOR PATIENTS WITHOUT HOSPITALIZATION REQUIREMENTS TO SUPPORT GROWTH 111
TABLE 64 MEDICAL SUPPLIES MARKET FOR CLINICS/PHYSICIAN OFFICES, BY REGION, 2019–2027 (USD MILLION) 111
8.4 OTHER END USERS 112
TABLE 65 MEDICAL SUPPLIES MARKET FOR OTHER END USERS, BY REGION,
2019–2027 (USD MILLION) 112
9 MEDICAL SUPPLIES MARKET, BY REGION 113
9.1 INTRODUCTION 114
TABLE 66 MEDICAL SUPPLIES MARKET, BY REGION, 2019–2027 (USD MILLION) 114
9.2 NORTH AMERICA 114
FIGURE 20 NORTH AMERICA: MEDICAL SUPPLIES MARKET SNAPSHOT 115
TABLE 67 NORTH AMERICA: MEDICAL SUPPLIES MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 116
TABLE 68 NORTH AMERICA: MEDICAL SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 116
TABLE 69 NORTH AMERICA: DIAGNOSTIC SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 116
TABLE 70 NORTH AMERICA: DISINFECTANTS MARKET, BY TYPE,
2019–2027 (USD MILLION) 117
TABLE 71 NORTH AMERICA: PPE MARKET, BY TYPE, 2019–2027 (USD MILLION) 117
TABLE 72 NORTH AMERICA: WOUND CARE CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 117
TABLE 73 NORTH AMERICA: DIALYSIS CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 118
TABLE 74 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 118
TABLE 75 NORTH AMERICA: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 118
TABLE 76 NORTH AMERICA: MEDICAL SUPPLIES MARKET, BY END USER,
2019–2027 (USD MILLION) 119
9.2.1 US 119
9.2.1.1 Rapid rise in COVID-19 cases and the increasing incidence of chronic conditions drive the demand for medical supplies 119
TABLE 77 US: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 121
TABLE 78 US: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 121
9.2.2 CANADA 122
9.2.2.1 Supportive government initiatives against the increasing prevalence of chronic conditions in Canada drive the overall market growth 122
TABLE 79 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 123
TABLE 80 CANADA: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 124
TABLE 81 CANADA: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 124
9.3 EUROPE 125
TABLE 82 EUROPE: MEDICAL SUPPLIES MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 125
TABLE 83 EUROPE: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 126
TABLE 84 EUROPE: DIAGNOSTIC SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 126
TABLE 85 EUROPE: DISINFECTANTS MARKET, BY TYPE, 2019–2027 (USD MILLION) 126
TABLE 86 EUROPE: PPE MARKET, BY TYPE, 2019–2027 (USD MILLION) 127
TABLE 87 EUROPE: WOUND CARE CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 127
TABLE 88 EUROPE: DIALYSIS CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 127
TABLE 89 EUROPE: CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 128
TABLE 90 EUROPE: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 128
TABLE 91 EUROPE: MEDICAL SUPPLIES MARKET, BY END USER,
2019–2027 (USD MILLION) 128
9.3.1 GERMANY 129
9.3.1.1 The rising prevalence of chronic diseases and increasing healthcare expenditure drive the demand for medical supplies in Germany 129
TABLE 92 SURGICAL PROCEDURES PERFORMED IN GERMANY, 2019 130
TABLE 93 GERMANY: MEDICAL SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 130
TABLE 94 GERMANY: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 131
9.3.2 FRANCE 131
9.3.2.1 Increasing demand for medical supplies owing to the rising cases of COVID-19 supports the market growth 131
TABLE 95 SURGICAL PROCEDURES PERFORMED IN FRANCE, 2019 132
TABLE 96 FRANCE: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 132
TABLE 97 FRANCE: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 133
9.3.3 UK 133
9.3.3.1 Initiatives undertaken by government bodies in the UK are expected to offer opportunities for market growth 133
TABLE 98 SURGICAL PROCEDURES PERFORMED IN THE UK, 2019 134
TABLE 99 UK: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 135
TABLE 100 UK: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 135
9.3.4 ITALY 136
9.3.4.1 The large senior population in the country and high burden of chronic diseases have increased the demand for medical supplies 136
TABLE 101 SURGICAL PROCEDURES PERFORMED IN ITALY IN 2019 137
TABLE 102 ITALY: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 137
TABLE 103 ITALY: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 138
9.3.5 SPAIN 138
9.3.5.1 The high prevalence of HAIs in Spanish hospitals drives the demand for medical supplies 138
TABLE 104 SURGICAL PROCEDURES PERFORMED IN SPAIN IN 2019 139
TABLE 105 SPAIN: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 139
TABLE 106 SPAIN: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 140
9.3.6 REST OF EUROPE 140
TABLE 107 ROE: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 141
TABLE 108 ROE: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 141
9.4 ASIA PACIFIC 142
FIGURE 21 ASIA PACIFIC: MEDICAL SUPPLIES MARKET SNAPSHOT 143
TABLE 109 ASIA PACIFIC: MEDICAL SUPPLIES MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 144
TABLE 110 ASIA PACIFIC: MEDICAL SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 144
TABLE 111 ASIA PACIFIC: DIAGNOSTIC SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 145
TABLE 112 ASIA PACIFIC: DISINFECTANTS MARKET, BY TYPE,
2019–2027 (USD MILLION) 145
TABLE 113 ASIA PACIFIC: PPE MARKET, BY TYPE, 2019–2027 (USD MILLION) 145
TABLE 114 ASIA PACIFIC: WOUND CARE CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 146
TABLE 115 ASIA PACIFIC: DIALYSIS CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 146
TABLE 116 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 146
TABLE 117 ASIA PACIFIC: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 147
TABLE 118 ASIA PACIFIC: MEDICAL SUPPLIES MARKET, BY END USER,
2019–2027 (USD MILLION) 147
9.4.1 CHINA 147
9.4.1.1 Outbreak of COVID-19 and existing chronic diseases to accelerate demand for medical supplies 147
TABLE 119 CHINA: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 148
TABLE 120 CHINA: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 149
9.4.2 JAPAN 149
9.4.2.1 Large market size with best-equipped healthcare facilities to drive market growth 149
TABLE 121 JAPAN: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 150
TABLE 122 JAPAN: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 150
9.4.3 INDIA 151
9.4.3.1 Increasing number of start-up companies to propel market growth 151
TABLE 123 INDIA: MEDICAL SUPPLIES MARKET, BY TYPE, 2019–2027 (USD MILLION) 152
TABLE 124 INDIA: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 152
9.4.4 REST OF ASIA PACIFIC 153
TABLE 125 SURGICAL PROCEDURES IN SOUTH KOREA, 2019 154
TABLE 126 REST OF ASIA PACIFIC: MEDICAL SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 155
TABLE 127 REST OF ASIA PACIFIC: MEDICAL SUPPLIES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 155
9.5 REST OF THE WORLD 156
TABLE 128 MIDDLE EAST & AFRICA: COVID-19 CASES 156
TABLE 129 LATIN AMERICA: COVID-19 CASES 157
TABLE 130 REST OF THE WORLD: MEDICAL SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 158
TABLE 131 REST OF THE WORLD: DIAGNOSTIC SUPPLIES MARKET, BY TYPE,
2019–2027 (USD MILLION) 158
TABLE 132 REST OF THE WORLD: DISINFECTANTS MARKET, BY TYPE,
2019–2027 (USD MILLION) 159
TABLE 133 REST OF THE WORLD: PPE MARKET, BY TYPE, 2019–2027 (USD MILLION) 159
TABLE 134 REST OF THE WORLD: WOUND CARE CONSUMABLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 159
TABLE 135 REST OF THE WORLD: DIALYSIS CONSUMABLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 160
TABLE 136 REST OF THE WORLD: CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 160
TABLE 137 REST OF THE WORLD: MEDICAL SUPPLIES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 160
TABLE 138 REST OF THE WORLD: MEDICAL SUPPLIES MARKET, BY END USER,
2019–2027 (USD MILLION) 161
 
10 COMPETITIVE LANDSCAPE 162
10.1 OVERVIEW 162
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 162
TABLE 139 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE MEDICAL SUPPLIES MARKET (2019 TO 2022) 162
10.3 COMPANY RANK ANALYSIS IN MEDICAL SUPPLIES MARKET, 2021 164
TABLE 140 MEDICAL SUPPLIES MARKET: DEGREE OF COMPETITION 164
10.4 COMPANY RANK ANALYSIS OF DIALYSIS CONSUMABLES MARKET, 2021 165
TABLE 141 DIALYSIS CONSUMABLES MARKET: MARKET RANK 165
10.5 COMPANY RANK ANALYSIS OF STERILIZATION AND INFECTION
CONTROL SUPPLIES MARKET, 2021 166
TABLE 142 STERILIZATION AND INFECTION CONTROL SUPPLIES MARKET: MARKET RANK 166
10.6 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 167
10.6.1 STARS 167
10.6.2 PERVASIVE PLAYERS 167
10.6.3 EMERGING LEADERS 167
10.6.4 PARTICIPANTS 167
FIGURE 22 MEDICAL SUPPLIES MARKET: COMPANY EVALUATION QUADRANT, 2021 168
10.7 COMPANY EVALUATION QUADRANT (SMES/START-UPS) 168
10.7.1 PROGRESSIVE COMPANIES 168
10.7.2 RESPONSIVE COMPANIES 169
10.7.3 STARTING BLOCKS 169
10.7.4 DYNAMIC COMPANIES 169
FIGURE 23 MEDICAL SUPPLIES MARKET: COMPANY EVALUATION
QUADRANT FOR START-UPS/SMES, 2021 169
10.8 COMPETITIVE BENCHMARKING 170
TABLE 143 COMPANY PRODUCT FOOTPRINT 170
TABLE 144 COMPANY REGIONAL FOOTPRINT 171
TABLE 145 OVERALL COMPANY FOOTPRINT 172
10.9 COMPETITIVE SITUATION AND TRENDS 173
10.9.1 PRODUCT LAUNCHES AND APPROVALS 173
TABLE 146 PRODUCT LAUNCHES AND APPROVALS, 2019–2022 173
10.9.2 DEALS 174
TABLE 147 DEALS, 2019–2022 174
10.9.3 OTHER DEVELOPMENTS 175
TABLE 148 OTHER DEVELOPMENTS, 2019–2022 175
 
11 COMPANY PROFILES 176
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS 176
11.1.1 MEDTRONIC PLC 176
TABLE 149 MEDTRONIC PLC: COMPANY OVERVIEW 176
FIGURE 24 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 177
11.1.2 CARDINAL HEALTH 182
TABLE 150 CARDINAL HEALTH: COMPANY OVERVIEW 182
FIGURE 25 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 183
11.1.3 BECTON, DICKINSON AND COMPANY 189
TABLE 151 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 189
FIGURE 26 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 190
11.1.4 JOHNSON & JOHNSON SERVICES, INC. 196
TABLE 152 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 196
FIGURE 27 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2021) 197
11.1.5 B. BRAUN MELSUNGEN AG 202
TABLE 153 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 202
FIGURE 28 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021) 203
11.1.6 BOSTON SCIENTIFIC CORPORATION 214
TABLE 154 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 214
FIGURE 29 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 215
11.1.7 THERMO FISHER SCIENTIFIC INC. 219
TABLE 155 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 219
FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 220
11.1.8 BAXTER 223
TABLE 156 BAXTER: COMPANY OVERVIEW 223
FIGURE 31 BAXTER: COMPANY SNAPSHOT (2021) 224
11.1.9 3M 230
TABLE 157 3M: COMPANY OVERVIEW 230
FIGURE 32 3M: COMPANY SNAPSHOT (2021) 231
11.1.10 SMITH & NEPHEW 234
TABLE 158 SMITH & NEPHEW: COMPANY OVERVIEW 234
FIGURE 33 SMITH & NEPHEW: COMPANY SNAPSHOT (2021) 235
11.1.11 CONVATEC INC. 238
TABLE 159 CONVATEC INC.: COMPANY OVERVIEW 238
FIGURE 34 CONVATEC INC.: COMPANY SNAPSHOT (2021) 239
11.1.12 ABBOTT 241
TABLE 160 ABBOTT.: COMPANY OVERVIEW 241
FIGURE 35 ABBOTT.: COMPANY SNAPSHOT (2021) 242
11.1.13 MERIT MEDICAL SYSTEMS 244
TABLE 161 MERIT MEDICAL SYSTEMS.: COMPANY OVERVIEW 244
FIGURE 36 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2021) 245
11.1.14 STRYKER 247
TABLE 162 STRYKER: COMPANY OVERVIEW 247
FIGURE 37 STRYKER: COMPANY SNAPSHOT (2021) 248
11.1.15 TERUMO CORPORATION 251
TABLE 163 TERUMO CORPORATION.: COMPANY OVERVIEW 251
FIGURE 38 TERUMO CORPORATION: COMPANY SNAPSHOT (2021) 252
11.1.16 TELEFLEX INCORPORATED 255
TABLE 164 TELEFLEX INCORPORATED.: COMPANY OVERVIEW 255
FIGURE 39 TELEFLEX INCORPORATED.: COMPANY SNAPSHOT (2021) 256
11.2 OTHER PLAYERS 259
11.2.1 FRESENIUS MEDICAL CARE AG & CO. KGAA 259
TABLE 165 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY OVERVIEW 259
11.2.2 COLOPLAST GROUP 260
TABLE 166 COLOPLAST GROUP: COMPANY OVERVIEW 260
11.2.3 COOK MEDICAL 261
TABLE 167 COOK MEDICAL: COMPANY OVERVIEW 261
11.2.4 HAMILTON MEDICAL 262
TABLE 168 HAMILTON MEDICAL: COMPANY OVERVIEW 262
11.2.5 ACELL, INC. 263
TABLE 169 ACELL, INC.: COMPANY OVERVIEW 263
11.2.6 INVACARE CORPORATION 264
TABLE 170 INVACARE CORPORATION: COMPANY OVERVIEW 264
11.2.7 MEDLINE INDUSTRIES, INC. 265
TABLE 171 MEDLINE INDUSTRIES, INC: COMPANY OVERVIEW 265
11.2.8 DEROYAL INDUSTRIES, INC. 266
TABLE 172 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 266
11.2.9 SHENZHEN MEDRENA BIOTECH CO., LTD. 268
TABLE 173 SHENZHEN MEDRENA BIOTECH CO., LTD.: COMPANY OVERVIEW 268
11.2.10 KERECIS 269
TABLE 174 KERECIS: COMPANY OVERVIEW 269
11.2.11 WHITELEY 270
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 271
12.1 INSIGHTS FROM INDUSTRY EXPERTS 271
12.2 DISCUSSION GUIDE 272
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 277
12.4 AVAILABLE CUSTOMIZATION OPTIONS 279
12.5 RELATED REPORTS 279
12.6 AUTHOR DETAILS 281